Journal Article

Multiple Transport-Active Binding Sites Are Available for a Single Substrate on Human P-Glycoprotein (ABCB1)

Sim, Hong-May, Talele, Tanaji T., Ambudkar, Suresh V., Singh, Satyakam, Durell, Stewart R., Chufan, Eduardo E., Kapoor, Khyati

2013

Overview

P-glycoprotein (Pgp, ABCB1) is an ATP-Binding Cassette (ABC) transporter that is associated with the development of multidrug resistance in cancer cells. Pgp transports a variety of chemically dissimilar amphipathic compounds using the energy from ATP hydrolysis. In the present study, to elucidate the binding sites on Pgp for substrates and modulators, we employed site-directed mutagenesis, cell- and membrane-based assays, molecular modeling and docking. We generated single, double and triple mutants with substitutions of the Y307, F343, Q725, F728, F978 and V982 residues at the proposed drug-binding site with cys in a cysless Pgp, and expressed them in insect and mammalian cells using a baculovirus expression system. All the mutant proteins were expressed at the cell surface to the same extent as the cysless wild-type Pgp. With substitution of three residues of the pocket (Y307, Q725 and V982) with cysteine in a cysless Pgp, QZ59S-SSS, cyclosporine A, tariquidar, valinomycin and FSBA lose the ability to inhibit the labeling of Pgp with a transport substrate, [(125)I]-Iodoarylazidoprazosin, indicating these drugs cannot bind at their primary binding sites. However, the drugs can modulate the ATP hydrolysis of the mutant Pgps, demonstrating that they bind at secondary sites. In addition, the transport of six fluorescent substrates in HeLa cells expressing triple mutant (Y307C/Q725C/V982C) Pgp is also not significantly altered, showing that substrates bound at secondary sites are still transported. The homology modeling of human Pgp and substrate and modulator docking studies support the biochemical and transport data. In aggregate, our results demonstrate that a large flexible pocket in the Pgp transmembrane domains is able to bind chemically diverse compounds. When residues of the primary drug-binding site are mutated, substrates and modulators bind to secondary sites on the transporter and more than one transport-active binding site is available for each substrate.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Adenosine Triphosphatases - metabolism / Adenosine Triphosphate - metabolism / Analysis / ATP / ATP Binding Cassette Transporter, Sub-Family B / ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors / ATP-Binding Cassette, Sub-Family B, Member 1 - chemistry / ATP-Binding Cassette, Sub-Family B, Member 1 - genetics / ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism / Baculovirus / Binding Sites / Biochemistry / Biology / Cancer / Cell Line, Tumor / Cell surface / Cells (Biology) / Cyclosporins / Cysteine / Docking / Drugs / Energy consumption / Fluorescence / Fluorescent Dyes - chemistry / Fluorescent Dyes - metabolism / Gene Expression / Glycoproteins / Health sciences / HeLa Cells / Homology / Humans / Hydrolysis / Insects / Laboratories / Mammalian cells / Medical research / Microbial drug resistance / Modelling / Models, Molecular / Modulators / Molecular Docking Simulation / Molecular modelling / Multidrug resistance / Mutagenesis / Mutagenesis, Site-Directed / Mutants / Mutation / P-Glycoprotein / Peptides / Pharmaceutical sciences / Pharmacy / Protein Binding / Protein Conformation / Protein Interaction Domains and Motifs / Proteins / Residues / Site-directed mutagenesis / Substrates / Transduction, Genetic / Transmembrane domains / Transport / Valinomycin